Pathways' Picks November 6: Medicare Rulemaking Edition

article image

The Centers for Medicare & Medicaid Services finalized more than 4,000 pages worth of 2020 payment regulations last week, with some important implications for device firms. In this edition of Pathways’ Picks, a look at some key policy decisions in the rules, with a focus on medtech disappointments tied to policies countering the opioid epidemic. Also, more news to watch and dates to remember.

CMS wrestled with the opioid abuse epidemic in its latest round of annual payment rules, but device firms’ efforts to better position medical technologies as alternatives to opioids for treating pain were mostly unsuccessful. Those outcomes lead this week’s Pathways’ Picks—a rundown of medtech policy happenings and key dates that should be on your radar.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: